Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-18-050983
Filing Date
2018-09-26
Accepted
2018-09-26 21:14:49
Documents
1
Period of Report
2018-09-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv503609_3.html 3  
1 OWNERSHIP DOCUMENT tv503609_3.xml 3 8499
  Complete submission text file 0001144204-18-050983.txt   11050
Mailing Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116
Business Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116 6177782500
RA Capital Healthcare Fund LP (Reporting) CIK: 0001315082 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38672 | Film No.: 181089286

Mailing Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116
Business Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, LLC (Reporting) CIK: 0001346824 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38672 | Film No.: 181089284

Mailing Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116
Business Address
Kolchinsky Peter (Reporting) CIK: 0001384859 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38672 | Film No.: 181089285

Mailing Address 395 WINCHESTER COMPANY, LLC 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER COMPANY, LLC 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS HOLDING COMPANY, LLC (Issuer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations